Brief: Astrazeneca To Acquire Gracell, Furthering Cell Therapy Ambition Across Oncology And Autoimmune Diseases

Gracell Biotechnologies

26/12/2023 07:04

Dec 26 (Reuters) - Astrazeneca  AZN.L :
    * TO ACQUIRE GRACELL, FURTHERING CELL THERAPY AMBITION
ACROSS
ONCOLOGY AND AUTOIMMUNE DISEASES
    * GRACELL WILL OPERATE AS A WHOLLY OWNED SUBSIDIARY OF
ASTRAZENECA, WITH OPERATIONS IN CHINA AND US
    * TRANSACTION DOES NOT IMPACT ASTRAZENECA'S FINANCIAL
GUIDANCE FOR
2023.

Source text for Eikon:  ID:nBw8K7XPva 
Further company coverage:  AZN.L 

 ((Reuters.Briefs@thomsonreuters.com;))